Seminars in Diagnostic Pathology
Volume 24, Issue 3 , Pages 162-182 , August 2007

Histiocytic lesions and proliferations in the lung

  • Chih-wei Wang, MD
    • ,
  • Thomas V. Colby, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Thomas V. Colby, MD, Mayo Clinic Arizona, Mayo Clinic College of Medicine, 13400 East Shea Boulevard, Scottsdale, AZ 85259.

References 

  1. Acute and chronic inflammation. In:  Kumar V,  Abbas AK,  Fausto N editor. Pathologic Basis of Disease. (ed 7). Philadelphia, PA: Elsevier Saunders; 2005;p. 47–86
  2. Yong-Jun L. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106:259–262
  3. Jansen HM. The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Allergy. 1996;51:279–292
  4. de Heer HJ, Hammad H, Kool M, et al. Dendritic cell subsets and immune regulation in the lung. Semin Immunol. 2005;17:295–303
  5. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med. 2005;172:530–551
  6. Wright-Browne V, McClain KL, Talpaz M, et al. Physiology and pathophysiology of dendritic cells. Hum Pathol. 1997;28:563–579
  7. Thomas R, Lipsky PE. Dendritic cells: origin and differentiation. Stem Cells. 1996;14:196–206
  8. van Nierop K, de Groot C. Human follicular dendritic cells: function, origin and development. Semin Immunol. 2002;14:251–257
  9. Jaffe R. Disorders of histiocytes. In:  Hsi ED editors. Hematopathology. Philadelphia, PA: Churchill Livingstone Elsevier; 2007;p. 513–550
  10. Cheung OY, Muhm JR, Helmers RA, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol. 2003;7:127–138
  11. Weiss LM, Grogan TM, Muller-Hermelink HK, et al: Histiocytic and dendritic cell neoplasms, in Jaffe ES, Harris NL, Stein H, et al (eds): World Health Organization of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, pp 273-289
  12. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133–1144
  13. Stark P. Reticulum cell sarcoma (large cell or histiocytic lymphoma) of the lung as a rare cause of intrapulmonary cavitation (A case report). Radiologe. 1981;21:142–143
  14. Lee JS, Ko GH, Kim HC, et al. Langerhans cell sarcoma arising from langerhans cell histiocytosis: a case report. J Korean Med Sci. 2006;21:577–580
  15. Julg BD, Weidner S, Mayr D. Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature. Virchows Arch. 2006;448:369–374
  16. Vives S, Fernandez MT, Lopez de Castro PE, et al. Interdigitating dendritic cell sarcoma with localization to the lung. Med Clin (Barc). 2006;126:559
  17. Shah RN, Ozden O, Yeldandi A, et al. Follicular dendritic cell tumor presenting in the lung: a case report. Hum Pathol. 2001;32:745–749
  18. Kovacs RB, Sattar HA, Krausz T, et al. Primary follicular dendritic cell sarcoma of the lung. Histopathology. 2006;49:431–433
  19. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med. 2002;346:484–490
  20. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans’-cell histiocytosis. N Engl J Med. 2000;342:1969–1978
  21. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001;25:630–636
  22. Willman CL. Detection of clonal histiocytes in Langerhans’ cell histiocytosis: biology and clinical significance. Br J Cancer Suppl. 1994;23:S29–S33
  23. Willman CL, Busque L, Griffith BB, et al. Langerhans’ cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med. 1994;331:154–160
  24. Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans’ cells in Langerhans’ cell histiocytosis. Lancet. 1994;343:767–768
  25. Churg A, Green FH. Occupational lung disease. In:  Churg A editors. Thurlbeck‘s Pathology of the Lung. (ed 3). New York, NY: Thieme Medical Publishers; 2005;p. 769–842
  26. Saltini C, Amicosante M. Beryllium disease. Am J Med Sci. 2001;321:89–98
  27. Rossman MD. Chronic beryllium disease: diagnosis and management. Environ Health Perspect. 1996;104(suppl 5):945–947
  28. Lapp NL, Parker JE. Coal workers’ pneumoconiosis. Clin Chest Med. 1992;13:243–252
  29. Stark P, Jacobson F, Shaffer K. Standard imaging in silicosis and coal worker’s pneumoconiosis. Radiol Clin North Am. 1992;30:1147–1154
  30. Brichet A, Tonnel AB, Brambilla E, et al. Chronic interstitial pneumonia with honeycombing in coal workers. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:211–219
  31. Green FH, Althouse R, Weber KC. Prevalence of silicosis at death in underground coal miners. Am J Ind Med. 1989;16:605–615
  32. Silicosis and Silicate Disease Committee. Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med. 1988;112:673–720
  33. Jederlinic PJ, Abraham JL, Churg A. Pulmonary fibrosis in aluminum oxide workers (Investigation of nine workers, with pathologic examination and microanalysis in three of them). Am Rev Respir Dis. 1990;142:1179–1184
  34. De Vuyst P, Dumortier P, Schandene L, et al. Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis. 1987;135:493–497
  35. Herbert A, Sterling G, Abraham J, et al. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol. 1982;13:694–699
  36. Miller RR, Churg AM, Hutcheon M, et al. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis. 1984;130:312–315
  37. Yamanaka A, Saiki S, Tamura S, et al. Problems in chronic obstructive bronchial disease, with special reference to diffuse panbronchiolitis. Naika. 1969;23:442–451
  38. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest. 1983;83:63–69
  39. Poletti V, Patelli M, Poletti G, et al. Diffuse panbronchiolitis observed in an Italian. Chest. 1990;98:515–616
  40. Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America (Report of three cases and review of the literature). Am J Surg Pathol. 1991;15:43–47
  41. Kitachi M, Nishimura K, Izumi T. Diffuse panbronchiolitis. In:  Sharma OP editors. Lung Disease in the Tropics. New York, NY: Marcel Dekker; 1991;p. 479–509
  42. Bai JC, Mazure RM, Vazquez H, et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004;2:849–860
  43. Marth T. Whipple‘s disease. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and Practice of Infectious Diseases. (ed 6). Philadelphia, PA: Elsevier Churchill Livingstone; 2005;p. 1306–1310
  44. Muller SA, Vogt P, Altwegg M, et al. Deadly carousel or difficult interpretation of new diagnostic tools for Whipple’s disease: case report and review of the literature. Infection. 2005;33:39–42
  45. Sharma OP. Unusual systemic disorders associated with interstitial lung disease. Curr Opin Pulm Med. 2001;7:291–294
  46. Muir-Padilla J, Myers JB. Whipple disease: a case report and review of the literature. Arch Pathol Lab Med. 2005;129:933–936
  47. Durand DV, Lecomte C, Cathebras P, et al. The SNFMI Research Group on Whipple Disease Societe Nationale Francaise de Medecine Interne Medicine (Baltimore) Whipple disease (Clinical review of 52 cases). 1997;76:170–184
  48. Kelly CA, Egan M, Rawlinson J, et al. Whipple’s disease presenting with lung involvement. Thorax. 1996;51:343–344
  49. Lepidi H, Fenollar F, Gerolami R, et al. Whipple’s disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens. Hum Pathol. 2003;34:589–596
  50. Raoult D, Birg ML, La Scola B, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med. 2000;342:620–625
  51. Weinstock DM, Brown AE. Rhodococcus equi: an emerging pathogen. Clin Infect Dis. 2002;34:1379–1385
  52. Scott MA, Graham BS, Verrall R, et al. Rhodococcus equi–an increasingly recognized opportunistic pathogen (Report of 12 cases and review of 65 cases in the literature). Am J Clin Pathol. 1995;103:649–655
  53. Guerrero MF, Ramos JM, Renedo G, et al. Pulmonary malacoplakia associated with Rhodococcus equi infection in patients with AIDS: case report and review. Clin Infect Dis. 1999;28:1334–1336
  54. Shin MS, Cooper JA, Ho KJ. Pulmonary malacoplakia associated with Rhodococcus equi infection in a patient with AIDS. Chest. 1999;115:889–892
  55. Bastas A, Markou N, Botsi C, et al. Malakoplakia of the lung caused by Pasteurella multocida in a patient with AIDS. Scand J Infect Dis. 2002;34:536–538
  56. Hodder RV, St George-Hyslop P, Chalvardjian A, et al. Pulmonary malakoplakia. Thorax. 1984;39:70–71
  57. Colby TV, Hunt S, Pelzmann K, et al. Malakoplakia of the lung: a report of two cases. Respiration. 1980;39:295–299
  58. Solis OG, Belmonte AH, Ramaswamy G, et al. Pseudogaucher cells in Mycobacterium avium intracellulare infections in acquired immune deficiency syndrome (AIDS). Am J Clin Pathol. 1986;85:233–235
  59. Argiris A, Maun N, Berliner N. Mycobacterium avium complex inclusions mimicking Gaucher’s cells. N Engl J Med. 1999;340:1372
  60. Dunn P, Kuo MC, Sun CF. Pseudo-Gaucher cells in mycobacterial infection: a report of two cases. J Clin Pathol. 2005;58:1113–1114
  61. Ionescu DN, Pierson DM, Qing G, et al. Pulmonary crystal-storing histiocytoma. Arch Pathol Lab Med. 2005;129:1159–1163
  62. Prasad ML, Charney DA, Sarlin J, et al. Pulmonary immunocytoma with massive crystal storing histiocytosis: a case report with review of literature. Am J Surg Pathol. 1998;22:1148–1153
  63. Kazzaz B, Dewar A, Corrin B. An unusual pulmonary plasmacytoma. Histopathology. 1992;21:285–287
  64. Papla B, Spolnik P, Rzenno E, et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch. 2004;445:83–89
  65. Jones D, Renshaw AA. Recurrent crystal-storing histiocytosis of the lung in a patient without a clonal lymphoproliferative disorder. Arch Pathol Lab Med. 1996;120:978–980
  66. Azzam I, Tov N, Elias N, et al. Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge. Postgrad Med J. 2006;82:73–75
  67. Aubry MC, Wright JL, Myers JL. The pathology of smoking-related lung diseases. Clin Chest Med. 2000;21:11–35
  68. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc. 1989;64:1373–1380
  69. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–1315
  70. Colby TV, Fukuoka J, Ewaskow SP, et al. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol. 2001;5:309–319
  71. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy. 2005;60:841–857
  72. Diffuse parenchymal lung diseases. In:  Travis WD,  Colby TV,  Koss MN, et al. editor. Atlas of Nontumor Pathology (fascicle 2) (Non-Neoplastic Disorders of the Lower Respiratory Tract). Washington, DC: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002;p. 160–169
  73. Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med. 2002;41:1016–1020
  74. Shiota Y, Kawai T, Matsumoto H, et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med. 2000;39:830–833
  75. Tazelaar HD, Linz LJ, Colby TV, et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med. 1997;155:296–302
  76. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med. 1969;280:787–798
  77. Rosati LA, Lesile KO. Lung infections. In:  Lesile KO,  Wick MR editor. Practical Pulmonary Pathology. Philadelphia, PA: Elsevier Churchill Livingstone; 2005;p. 136–137
  78. Perfect JR. Cryptococcus neoformans. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and Practice of Infectious Diseases. (ed 6). Philadelphia, PA: Elsevier Churchill Livingstone; 2005;p. 2997–3011
  79. Deepe GS. Histoplasma capsulatum. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and Practice of Infectious Diseases. (ed 6). Philadelphia, PA: Elsevier Churchill Livingstone; 2005;p. 3012–3025
  80. Wheat LJ. Histoplasmosis. In:  Sarosi GA,  Davies SF editor. Fungal Diseases of the Lung. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;p. 31–46
  81. Burke M, Fraser R. Obstructive pneumonitis: a pathologic and pathogenetic reappraisal. Radiology. 1988;166:699–704
  82. Tamura A, Hebisawa A, Fukushima K, et al. Lipoid pneumonia in lung cancer: radiographic and pathological features. Jpn J Clin Oncol. 1998;28:492–496
  83. Cohen AB, Cline MJ. In vitro studies of the foamy macrophage of postobstructive endogenous lipoid pneumonia in man. Am Rev Respir Dis. 1972;106:69–78
  84. Laurent F, Philippe JC, Vergier B, et al. Exogenous lipoid pneumonia: HRCT, MR, and pathologic findings. Eur Radiol. 1999;9:1190–1196
  85. Spickard A, Hirschmann JV. Exogenous lipoid pneumonia. Arch Intern Med. 1994;154:686–692
  86. Sprince NL, Oliver LC, Eisen EA, et al. Cobalt exposure and lung disease in tungsten carbide production (A cross-sectional study of current workers). Am Rev Respir Dis. 1988;138:1220–1226
  87. Nemery B, Nagels J, Verbeken E, et al. Rapidly fatal progression of cobalt lung in a diamond polisher. Am Rev Respir Dis. 1990;141:1373–1378
  88. Cugell DW. The hard metal diseases. Clin Chest Med. 1992;13:269–279
  89. Ohori NP, Sciurba FC, Owens GR, et al. Giant-cell interstitial pneumonia and hard-metal pneumoconiosis (A clinicopathologic study of four cases and review of the literature). Am J Surg Pathol. 1989;13:581–587
  90. Occupational lung disease and pneumoconioses. In:  Travis WD,  Colby TV,  Koss MN, et al. editor. Atlas of Nontumor Pathology (fascicle 2) (Non-Neoplastic Disorders of the Lower Respiratory Tract). Washington, DC: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002;p. 840–842
  91. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 1990;82:51–59
  92. Camus P, Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Clin Chest Med. 2004;25:65–75
  93. Iskandar SB, Abi-Saleh B, Keith RL, et al. Amiodarone-induced alveolar hemorrhage. South Med J. 2006;99:383–387
  94. Martin WJ, Kachel DL, Vilen T, et al. Mechanism of phospholipidosis in amiodarone pulmonary toxicity. J Pharmacol Exp Ther. 1989;251:272–278
  95. Liu FL, Cohen RD, Downar E, et al. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax. 1986;41:100–105
  96. Adams PC, Gibson GJ, Morley AR. Amiodarone pulmonary toxicity: clinical and subclinical features. Q J Med. 1986;59:449–471
  97. Lantuejoul S, Brambilla E, Brambilla C, et al. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J. 2002;19:577–580
  98. Amir G, Ron N. Pulmonary pathology in Gaucher’s disease. Hum Pathol. 1999;30:666–670
  99. Miller A, Brown LK, Pastores GM, et al. Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genet. 2003;63:368–376
  100. Nicholson AG, Florio R, Hansell DM, et al. Pulmonary involvement by Niemann-Pick disease (A report of six cases). Histopathology. 2006;48:596–603
  101. Minai OA, Sullivan EJ, Stoller JK. Pulmonary involvement in Niemann-Pick disease: case report and literature review. Respir Med. 2000;94:1241–1251
  102. Brown LK, Miller A, Bhuptani A, et al. Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med. 1997;155:1004–1010
  103. Matsumoto T, Matsumori H, Taki T, et al. Infantile GM1-gangliosidosis with marked manifestation of lungs. Acta Pathol Jpn. 1979;29:269–276
  104. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19–73
  105. Ohori NP, Yu J, Landreneau RJ, et al. Rosai-Dorfman disease of the pleura: a rare extranodal presentation. Hum Pathol. 2003;34:1210–1211
  106. Bonetti F, Chilosi M, Menestrina F, et al. Immunohistological analysis of Rosai-Dorfman histiocytosis (A disease of S-100 + CD1-histiocytes). Virchows Arch A Pathol Anat Histopathol. 1987;411:129–135
  107. Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol. 1995;91:415–418
  108. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D. Erdheim-Chester disease (Clinical and radiologic characteristics of 59 cases). Medicine (Baltimore). 1996;75:157–169
  109. Alper MG, Zimmerman LE, Piana FG, et al. Orbital manifestations of Erdheim-Chester disease. Trans Am Ophthalmol Soc. 1983;81:64–85
  110. Rush WL, Andriko JA, Galateau-Salle F. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol. 2000;13:747–754
  111. Egan AJ, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol. 1999;23:17–26

PII: S0740-2570(07)00072-X

doi: 10.1053/j.semdp.2007.06.003

Seminars in Diagnostic Pathology
Volume 24, Issue 3 , Pages 162-182 , August 2007

Article Tools

* Image Usage & Resolution